Ubtech, Robotics

Ubtech Robotics Stock Surges on Breakthrough Humanoid Sales

05.04.2026 - 04:34:19 | boerse-global.de

Ubtech's humanoid robot revenue surged 2,200% in 2025, driving a 53% total revenue increase to CNY 2B and significantly improving gross margins.

Ubtech Robotics Stock Surges on Breakthrough Humanoid Sales - Foto: über boerse-global.de

Ubtech Robotics Corp. has reported a transformative financial performance for 2025, driven overwhelmingly by the explosive growth of its large-scale humanoid robot division. The Chinese robotics manufacturer saw its total revenue leap by 53.3% to CNY 2.001 billion, a surge anchored by a product category that was virtually non-existent just a few years prior.

Financial Turnaround Fueled by High-Margin Robots

The company’s strategic pivot is yielding significant financial improvements. Ubtech’s consolidated gross margin expanded to 37.7%, marking a substantial nine-percentage-point increase from the previous year. This improvement contributed to a narrowing of the firm’s net loss, which fell to CNY 789.8 million from over CNY 1.1 billion.

At the core of this shift is the "Full-Size Embodied Intelligent Humanoid" business unit. Revenue for this segment skyrocketed by an astonishing 2,203.7% to reach CNY 820 million. During the period, Ubtech sold 1,079 units at an average price of approximately CNY 760,000 each.

This segment is now the primary engine for both growth and profitability. It boasts a gross margin of 54.6% and is responsible for generating 59% of the company’s total gross profit.

Should investors sell immediately? Or is it worth buying Ubtech Robotics?

Robust R&D Spending and Financial Health

Despite reporting a net loss, Ubtech maintains a strong balance sheet. The firm ended the year with cash reserves of CNY 4.92 billion. It continues to invest heavily in future innovation, allocating more than CNY 500 million to research and development in 2025. This R&D expenditure represents 25.4% of its total revenue.

Market analysts have responded positively to the results. Citi reaffirmed its "Buy" rating on the stock, setting a price target of 155 HKD. The bank’s analysts highlighted Ubtech’s leading global sales volume in humanoid robotics and its successful strategic refocusing on industrial and commercial applications.

Investors had already begun pricing in the positive news earlier in the week. Shares gained roughly 17% following the initial release of key annual report data, even as broader market sentiment remained weighed down by ongoing geopolitical tensions.

Ubtech Robotics at a turning point? This analysis reveals what investors need to know now.

With its expanding margins, solid liquidity position, and clear strategic focus on industrial humanoid systems, Ubtech appears well-positioned to navigate the increasingly competitive global humanoid robotics market. Its continued success, however, remains contingent on sustained demand growth from the industrial sector.

Ad

Ubtech Robotics Stock: New Analysis - 5 April

Fresh Ubtech Robotics information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Ubtech Robotics analysis...

So schätzen die Börsenprofis Ubtech Aktien ein!

<b>So schätzen die Börsenprofis Ubtech Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
CNE100006CQ4 | UBTECH | boerse | 69076432 |